Ionis Pharmaceuticals (IONS) Tax Provisions (2009 - 2026)

Ionis Pharmaceuticals' Tax Provisions history runs 18 years deep, the most recent figure standing at $218000.0 for Q1 2026.

• On a quarterly basis, Tax Provisions rose 87.93% year-over-year to $218000.0 in Q1 2026; TTM through Mar 2026 was $12.2 million, a 203.37% increase from a year earlier, with the FY2025 full-year figure at $12.1 million, up 202.15% from the prior year.
• Tax Provisions slipped to $218000.0 in Q1 2026 per IONS's latest filing, from $11.8 million in the prior quarter.
• Across five years, Tax Provisions topped out at $11.8 million in Q4 2025 and bottomed at -$8.4 million in Q4 2024.
• The 5-year median for Tax Provisions is $218000.0 (2026), against an average of $1.7 million.
• Across the five-year window, Tax Provisions slumped 2027.79% in 2022 and soared 2232.16% in 2023, its largest moves.
• Year by year, Tax Provisions stood at -$6.7 million in 2022, then soared by 196.92% to $6.5 million in 2023, then sank by 228.94% to -$8.4 million in 2024, then soared by 240.78% to $11.8 million in 2025, then tumbled by 98.16% to $218000.0 in 2026.
• Per Business Quant, the three latest IONS Tax Provisions figures stand at $218000.0 (Q1 2026), $11.8 million (Q4 2025), and $213000.0 (Q3 2025).